Emergent BioSolutions EBS
NYSE EBS
$6.07 -0.03 (-0.49%)
As of: Nov 10, 2026 · 12:41 PM EST

Emergent BioSolutions (EBS) Operating Margin (2011 - 2026)

Updated

Emergent BioSolutions (EBS) recorded Operating Margin of -33.91% in Q3 2026, down 67.01 percentage points from 33.10% a year earlier but up 19.48 percentage points from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Operating Margin (2011 - 2026) Analysis & Trends

On a TTM basis, Emergent BioSolutions' Operating Margin came in at -27.70% as of Sep 30, 2026, down 42.72 percentage points year-over-year; for FY2025, it was 13.47%, up 23.89 percentage points from FY2024.

  • Annual Operating Margin has a five-year change of -14.33 percentage points (FY2020 to FY2025).
  • Across earlier years, Operating Margin came in at -10.42% in FY2024 (+58.81 pp), -69.23% in FY2023 (-54.01 pp), -15.21% in FY2022 (-34.46 pp) and 19.25% in FY2021 (-8.55 pp).
  • Quarterly Operating Margin has ranged from -89.84% in Q1 2023 to 39.13% in Q4 2021 over the past five years.
  • On a year-over-year basis, Operating Margin has declined for four consecutive quarters, with an average year-over-year change of -4.85 percentage points over the last eight quarters.
  • Peak year-over-year performance for Operating Margin in the last five years was a gain of 111.45 percentage points in Q3 2024, against a drop of 92.10 percentage points in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -53.39% (Q2 2026), 6.73% (Q1 2026) and -18.76% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 24.35%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 36.01%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 30.89%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 32.97%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 20.57%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 35.79%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 41.71%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 32.98%
10 Emergent BioSolutions 310.37 Mn -370.73 Mn 29.20 Mn -33.91%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -33.91%
Jun 30, 2026 -53.39%
Mar 31, 2026 6.73%
Dec 31, 2025 -18.76%
Sep 30, 2025 33.10%
Jun 30, 2025 1.14%
Mar 31, 2025 22.46%
Dec 31, 2024 -4.88%
Sep 30, 2024 21.95%
Jun 30, 2024 -79.90%
Mar 31, 2024 13.25%
Dec 31, 2023 -15.84%
Sep 30, 2023 -89.50%
Jun 30, 2023 -86.68%
Mar 31, 2023 -89.84%
Dec 31, 2022 -16.75%
Sep 30, 2022 -18.88%
Jun 30, 2022 -31.45%
Mar 31, 2022 2.26%
Dec 31, 2021 39.13%
API Access

Emergent BioSolutions Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY